Comment
doi: 10.1016/S0140-6736(09)60448-7.
Epub 2009 Mar 28.
Bringing JUPITER down to earth
Affiliations
- PMID: 19329179
- DOI: 10.1016/S0140-6736(09)60448-7
Item in Clipboard
Comment
Bringing JUPITER down to earth
Lancet.
.
No abstract available
Comment on
-
Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial.Lancet. 2009 Apr 4;373(9670):1175-82. doi: 10.1016/S0140-6736(09)60447-5. Epub 2009 Mar 28. Lancet. 2009. PMID: 19329177 Clinical Trial.
Similar articles
-
The editor's roundtable: the JUPITER trial--initial results and clinical implications.Am J Cardiol. 2009 May 15;103(10):1417-25. doi: 10.1016/j.amjcard.2009.02.023. Am J Cardiol. 2009. PMID: 19427439 No abstract available.
-
JUPITER study highlights value of anti-inflammatory action of rosuvastatin.Cardiovasc J Afr. 2009 May-Jun;20(3):211. Cardiovasc J Afr. 2009. PMID: 19575096 No abstract available.
-
Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.Lancet. 2009 Jul 4;374(9683):25; author reply 26-7. doi: 10.1016/S0140-6736(09)61231-9. Lancet. 2009. PMID: 19577690 No abstract available.
-
[JUPITER can yield paradigmatic shift in the prevention of cardiovascular disease. Focus on inflammation as a risk factor].Lakartidningen. 2009 May 20-Jun 2;106(21-22):1471-5. Lakartidningen. 2009. PMID: 19579435 Review. Swedish. No abstract available.
-
Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?Am J Cardiol. 2006 Jan 16;97(2A):33A-41A. doi: 10.1016/j.amjcard.2005.11.014. Epub 2005 Dec 1. Am J Cardiol. 2006. PMID: 16442935 Review.
Cited by
-
Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspective.Drug Des Devel Ther. 2010 Dec 9;4:383-413. doi: 10.2147/DDDT.S10812. Drug Des Devel Ther. 2010. PMID: 21267417 Free PMC article. Review.
-
Is Jupiter also a god of primary prevention?Tex Heart Inst J. 2010;37(1):6-7. Tex Heart Inst J. 2010. PMID: 20200621 Free PMC article. No abstract available.
-
Fenofibrate reduces systemic inflammation markers independent of its effects on lipid and glucose metabolism in patients with the metabolic syndrome.J Clin Endocrinol Metab. 2010 Feb;95(2):829-36. doi: 10.1210/jc.2009-1487. Epub 2010 Jan 8. J Clin Endocrinol Metab. 2010. PMID: 20061429 Free PMC article. Clinical Trial.
-
From evidence to practice: consensus in cardiovascular risk assessment and diabetes.Clin Biochem Rev. 2009 Nov;30(4):179-86. Clin Biochem Rev. 2009. PMID: 20011210 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
